
Keywords: A5; A5 catecholamine cell group; Amb; nucleus ambiguous; AP; area postrema; CNS; central nervous system; CVLM; caudal ventrolateral medulla; DAB; diaminobenzidine; DMH; dorsomedial hypothalamic nucleus; Fos-IR; Fos immunoreactivity; GAD; glutamic acid dec